J. T. Reilly

629 total citations
22 papers, 461 citations indexed

About

J. T. Reilly is a scholar working on Hematology, Genetics and Immunology and Allergy. According to data from OpenAlex, J. T. Reilly has authored 22 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Genetics and 6 papers in Immunology and Allergy. Recurrent topics in J. T. Reilly's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Cell Adhesion Molecules Research (6 papers) and Eosinophilic Disorders and Syndromes (4 papers). J. T. Reilly is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Cell Adhesion Molecules Research (6 papers) and Eosinophilic Disorders and Syndromes (4 papers). J. T. Reilly collaborates with scholars based in United Kingdom, Australia and United States. J. T. Reilly's co-authors include J R Nash, M.J. Mackie, B. A. McVerry, G. Dolan, S. Mac Neil, Alwyn Smith, Paul Forrest, David Barnett, Joseph M. Smith and Andrew J. Dalley and has published in prestigious journals such as Gut, Annals of the New York Academy of Sciences and Journal of Antimicrobial Chemotherapy.

In The Last Decade

J. T. Reilly

22 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. T. Reilly United Kingdom 12 198 193 88 82 75 22 461
M. Bérard France 15 225 1.1× 65 0.3× 105 1.2× 51 0.6× 201 2.7× 34 586
Francisca C. Gushiken United States 12 210 1.1× 63 0.3× 123 1.4× 50 0.6× 50 0.7× 20 492
SA Burstein United States 11 398 2.0× 103 0.5× 125 1.4× 30 0.4× 17 0.2× 20 575
Alton L. Lightsey United States 11 347 1.8× 52 0.3× 60 0.7× 160 2.0× 15 0.2× 23 579
Tommaso Stefanelli Italy 7 259 1.3× 97 0.5× 63 0.7× 22 0.3× 29 0.4× 24 490
Mitsuaki Kaizuka Japan 12 78 0.4× 33 0.2× 68 0.8× 29 0.4× 95 1.3× 23 426
G. Kaplanski France 9 63 0.3× 33 0.2× 134 1.5× 44 0.5× 90 1.2× 20 523
S T Fan United States 11 202 1.0× 41 0.2× 107 1.2× 151 1.8× 15 0.2× 11 546
Sandrine Lafarge France 10 207 1.0× 92 0.5× 88 1.0× 19 0.2× 18 0.2× 11 439
Emma Ross United Kingdom 7 136 0.7× 42 0.2× 100 1.1× 34 0.4× 293 3.9× 8 729

Countries citing papers authored by J. T. Reilly

Since Specialization
Citations

This map shows the geographic impact of J. T. Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. T. Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. T. Reilly more than expected).

Fields of papers citing papers by J. T. Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. T. Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. T. Reilly. The network helps show where J. T. Reilly may publish in the future.

Co-authorship network of co-authors of J. T. Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of J. T. Reilly. A scholar is included among the top collaborators of J. T. Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. T. Reilly. J. T. Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanson, Andrea, Kerry McGuire, Jorge Bardina, et al.. (2019). A Model-Based Systems Engineering Approach to Exploration Medical System Development. 1–19. 11 indexed citations
2.
Reilly, J. T., David A. Rubin, Andrea Hanson, et al.. (2017). Systems Engineering for Space Exploration Medical Capabilities. NASA STI Repository (National Aeronautics and Space Administration). 13 indexed citations
3.
Reilly, J. T., et al.. (2017). Exploration Medical Capability ConOps and Systems Engineering Technical Interchange Meeting Summary. 1 indexed citations
4.
Reilly, J. T., et al.. (2008). Bone marrow and serum connective tissue polypeptides in idiopathic myelofibrosis. Clinical & Laboratory Haematology. 17(1). 35–39. 3 indexed citations
5.
Dalley, Andrew J., Joseph M. Smith, J. T. Reilly, & S. Mac Neil. (1996). Investigation of calmodulin and basic fibroblast growth factor (bFGF) in idiopathic myelofibrosis: evidence for a role of extracellular calmodulin in fibroblast proliferation. British Journal of Haematology. 93(4). 856–862. 37 indexed citations
6.
Taylor, Peter C., et al.. (1996). Efficacy of recombinant interferon‐alpha (rIFN‐α) in polycythaemia vera: a study of 17 patients and an analysis of published data. British Journal of Haematology. 92(1). 55–59. 41 indexed citations
7.
Phillips, J., Chris Sherlaw‐Johnson, Rachel Pearce, et al.. (1995). A Randomized Study of MOD Versus VAD in the Treatment of Relapsed and Resistant Multiple Myeloma. Leukemia & lymphoma. 17(5). 465–472. 16 indexed citations
8.
Reilly, J. T., et al.. (1994). Raised urinary calmodulin levels in idiopathic myelofibrosis: possible implications for the aetiology of fibrosis. British Journal of Haematology. 86(3). 668–670. 7 indexed citations
9.
Snowden, John A., A Milford-Ward, & J. T. Reilly. (1994). Symptomatic IgG3 deficiency successfully treated with intravenous immunoglobulin therapy. Postgraduate Medical Journal. 70(830). 924–926. 7 indexed citations
10.
Bardhan, Karna Dev, et al.. (1993). Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease.. Gut. 34(10). 1310–1314. 12 indexed citations
11.
Reilly, J. T., et al.. (1993). Characterization of an acute micromegakaryocytic leukaemia: evidence for the pathogenesis of myelofibrosis. British Journal of Haematology. 83(1). 58–62. 57 indexed citations
12.
Bardhan, K. D., et al.. (1992). Mucosal Plasminogen Activator Activity in Peptic Ulcer Disease. Annals of the New York Academy of Sciences. 667(1). 181–182. 1 indexed citations
13.
Reilly, J. T.. (1992). Pathogenesis of idiopathic myelofibrosis: role of growth factors.. Journal of Clinical Pathology. 45(6). 461–464. 47 indexed citations
14.
Smith, Stacy, et al.. (1988). Amiloride prevents amphotericin B related hypokalaemia in neutropenic patients.. Journal of Clinical Pathology. 41(5). 494–497. 20 indexed citations
15.
Reilly, J. T. & J R Nash. (1988). Vitronectin (serum spreading factor): its localisation in normal and fibrotic tissue.. Journal of Clinical Pathology. 41(12). 1269–1272. 67 indexed citations
16.
Mackie, M.J., et al.. (1986). A randomized trial of Timentin and tobramycin versus piperacillin and tobramycin in febrile neutropenic patients. Journal of Antimicrobial Chemotherapy. 17(suppl C). 219–224. 11 indexed citations
17.
Reilly, J. T., J R Nash, M.J. Mackie, & B. A. McVerry. (1985). Distribution of fibronectin and laminin in normal and pathological lymphoid tissue.. Journal of Clinical Pathology. 38(8). 849–854. 32 indexed citations
18.
Reilly, J. T., M J Galloway, M.J. Mackie, & B. A. McVerry. (1984). Fibronectin C in acute leukaemia. British Journal of Haematology. 58(1). 83–90. 3 indexed citations
19.
Reilly, J. T., M.J. Mackie, & B. A. McVerry. (1984). Observations on the heterogeneity of fibronectin C. Thrombosis Research. 33(3). 289–295. 7 indexed citations
20.
Reilly, J. T., B. A. McVerry, & M.J. Mackie. (1983). Fibronectin in blood products--an in vitro and in vivo study.. Journal of Clinical Pathology. 36(12). 1377–1381. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Bérard Breakdown of academic impact, for papers by Francisca C. Gushiken Breakdown of academic impact, for papers by SA Burstein Breakdown of academic impact, for papers by Alton L. Lightsey Breakdown of academic impact, for papers by Tommaso Stefanelli Breakdown of academic impact, for papers by Mitsuaki Kaizuka Breakdown of academic impact, for papers by G. Kaplanski Breakdown of academic impact, for papers by S T Fan Breakdown of academic impact, for papers by Sandrine Lafarge Breakdown of academic impact, for papers by Emma Ross
Rankless by CCL
2026